Trial Profile
AN OPEN-LABEL, SINGLE-TREATMENT, SINGLE-PERIOD, SINGLE DOSE, CLINICAL PHASE 1 STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF LIVE RUBELLA VACCINE, (MULTIPLE DOSE VIAL FORMULATION) OF M/s CADILA HEALTHCARE LTD., INDIA IN HEALTHY, ADULT, MALE, HUMAN SUBJECTS UNDER FASTING CONDITION.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Aug 2016
Price :
$35
*
At a glance
- Drugs Rubella virus vaccine live (Primary)
- Indications Rubella
- Focus Adverse reactions
- Sponsors Cadila Healthcare
- 25 Sep 2012 Status changed from not stated to completed.
- 11 Sep 2012 New trial record